242 related articles for article (PubMed ID: 26675313)
41. Loose versus stranded seeds in permanent prostate brachytherapy: dosimetric comparison of intraoperative plans.
Major T; Agoston P; Fröhlich G; Baricza K; Szabo Z; Jorgo K; Herein A; Polgar C
Phys Med; 2014 Dec; 30(8):909-13. PubMed ID: 25175151
[TBL] [Abstract][Full Text] [Related]
42. A systematic study of imaging uncertainties and their impact on 125I prostate brachytherapy dose evaluation.
Lindsay PE; Van Dyk J; Battista JJ
Med Phys; 2003 Jul; 30(7):1897-908. PubMed ID: 12906208
[TBL] [Abstract][Full Text] [Related]
43. Dose escalation to the dominant intraprostatic lesion defined by sextant biopsy in a permanent prostate I-125 implant: a prospective comparative toxicity analysis.
Gaudet M; Vigneault E; Aubin S; Varfalvy N; Harel F; Beaulieu L; Martin AG
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):153-9. PubMed ID: 19665322
[TBL] [Abstract][Full Text] [Related]
44. Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry.
Su Y; Davis BJ; Furutani KM; Herman MG; Robb RA
Phys Med Biol; 2007 Jun; 52(11):3105-19. PubMed ID: 17505092
[TBL] [Abstract][Full Text] [Related]
45. Interstitial rotating shield brachytherapy for prostate cancer.
Adams QE; Xu J; Breitbach EK; Li X; Enger SA; Rockey WR; Kim Y; Wu X; Flynn RT
Med Phys; 2014 May; 41(5):051703. PubMed ID: 24784369
[TBL] [Abstract][Full Text] [Related]
46. Robustness to source displacement in dual air kerma strength planning for focal low-dose-rate brachytherapy of prostate cancer.
Mahdavi SS; Spadinger IT; Chng NT; Morris WJ
Brachytherapy; 2016; 15(5):642-9. PubMed ID: 27263060
[TBL] [Abstract][Full Text] [Related]
47. Focal or whole-gland salvage prostate brachytherapy with iodine seeds with or without a rectal spacer for postradiotherapy local failure: How best to spare the rectum?
Guimas V; Quivrin M; Bertaut A; Martin E; Chambade D; Maingon P; Mazoyer F; Cormier L; Créhange G
Brachytherapy; 2016; 15(4):406-411. PubMed ID: 27317949
[TBL] [Abstract][Full Text] [Related]
48. Optimal needle arrangement for intraoperative planning in permanent I-125 prostate implants.
Thompson SA; Fung AY; Zaider M
Phys Med Biol; 2002 Aug; 47(16):N209-15. PubMed ID: 12222865
[TBL] [Abstract][Full Text] [Related]
49. Optimal placement of radioisotopes for permanent prostate implants.
Narayana V; Roberson PL; Winfield RJ; Kessler ML; McLaughlin PW
Radiology; 1996 May; 199(2):457-60. PubMed ID: 8668794
[TBL] [Abstract][Full Text] [Related]
50. Loading technique comparison in permanent 125I prostate implants.
Williams BV; Horton J; Lawyer A; Chapman J
Med Dosim; 1999; 24(4):273-7. PubMed ID: 10643736
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of the MIM Symphony treatment planning system for low-dose-rate- prostate brachytherapy.
Dhanesar SK; Lim TY; Du W; Bruno TL; Frank SJ; Kudchadker RJ
J Appl Clin Med Phys; 2015 Sep; 16(5):62–75. PubMed ID: 26699290
[TBL] [Abstract][Full Text] [Related]
52. Intraoperative ultrasound-based planning can effectively replace postoperative CT-based planning for high-dose-rate brachytherapy for prostate cancer.
Batchelar DL; Chung HT; Loblaw A; Law N; Cisecki T; Morton GC
Brachytherapy; 2016; 15(4):399-405. PubMed ID: 27180126
[TBL] [Abstract][Full Text] [Related]
53. A comparison of anatomy-based inverse planning with simulated annealing and graphical optimization for high-dose-rate prostate brachytherapy.
Morton GC; Sankreacha R; Halina P; Loblaw A
Brachytherapy; 2008; 7(1):12-6. PubMed ID: 18037356
[TBL] [Abstract][Full Text] [Related]
54. An open-source genetic algorithm for determining optimal seed distributions for low-dose-rate prostate brachytherapy.
McGeachy P; Madamesila J; Beauchamp A; Khan R
Brachytherapy; 2015; 14(5):692-702. PubMed ID: 26023047
[TBL] [Abstract][Full Text] [Related]
55. [Permanent implant brachytherapy for early, organ-confined prostate cancer].
Agoston P; Major T; Fröhlich G; Baricza K; Szabó Z; Lövey J; Varjas G; Kásler M; Fodor J; Polgár C
Magy Onkol; 2011 Sep; 55(3):170-7. PubMed ID: 21918742
[TBL] [Abstract][Full Text] [Related]
56. Dose homogeneity as a function of source activity in optimized I-125 prostate implant treatment plans.
D'Souza WD; Meyer RR
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1120-30. PubMed ID: 11704337
[TBL] [Abstract][Full Text] [Related]
57. Initial comparison of inverse optimization, modified peripheral technique, and geometric optimization as real-time intraoperative computer planning options for permanent seed implantation of the prostate.
Raben A; Sammons S; Sim S; Chen H; Hanlon A; Sarkar A; Donavanik V; Grebler A; Geltzeiler J; Benge B; Glick A; Jacob D; Koprowski P
Brachytherapy; 2007; 6(4):238-45. PubMed ID: 17991621
[TBL] [Abstract][Full Text] [Related]
58. The robustness of dose distributions to displacement and migration of 125I permanent seed implants over a wide range of seed number, activity, and designs.
Beaulieu L; Archambault L; Aubin S; Oral E; Taschereau R; Pouliot J
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1298-308. PubMed ID: 15001275
[TBL] [Abstract][Full Text] [Related]
59. Inverse planning optimization for hybrid prostate permanent-seed implant brachytherapy plans using two source strengths.
Cunha JA; Pickett B; Pouliot J
J Appl Clin Med Phys; 2010 Jun; 11(3):3096. PubMed ID: 20717078
[TBL] [Abstract][Full Text] [Related]
60. A comparison of inverse optimization algorithms for HDR/PDR prostate brachytherapy treatment planning.
Dinkla AM; van der Laarse R; Kaljouw E; Pieters BR; Koedooder K; van Wieringen N; Bel A
Brachytherapy; 2015; 14(2):279-88. PubMed ID: 25447341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
